IFNA1 and COVID-19: Overall, our data demonstrate that specific members of the IFN families associate with mild or severe COVID-19, that the landscape of IFNs determines the ISGs induced in the upper airways, and that IFN-λ1 is uniquely capable of inducing potent anti-SARS-CoV-2 ISGs in patients with mild COVID-19.